Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Metastatic Brain Tumor

Metastatic Brain Tumor Newsletter

Advancing Brain Metastases Research and Mentorship in Breast Oncology: With D. Ross Camidge, MD, PhD; Nancy U. Lin, MD 30 Apr 2025 19:38 GMT
… for Patients with Breast Cancer Brain Metastases, medical director of the Breast … Lin's work with brain metastases, her role in developing targeted … of systemic therapy for managing brain metastases, and the significance of mentoring …
Boehringer's new zongertinib data demonstrates durable and clinically meaningful results in patients with HER2 (ERBB2)─mutant advanced NSCLC 30 Apr 2025 08:55 GMT
… =27, who were evaluable) with brain metastases, with 41% achieving response and …
J INTS BIO Presents Research Results for Next-Generation Innovative Anticancer Therapeutics 'JIN-A02' and 'JIN-001' at AACR 2025 30 Apr 2025 06:09 GMT
… for NSCLC patients, in whom brain metastases are common. Furthermore, no dose …
Investigators Discontinue Trial Assessing Capivasertib in Metastatic CRPC 30 Apr 2025 02:13 GMT
… the trial if they had brain metastases or spinal cord compression, cardiac …
Zongertinib delivers ‘meaningful benefit’ to patients with HER2-mutant NSCLC 29 Apr 2025 21:51 GMT
… , including in patients with brain metastases,” John V. Heymach, … and higher incidence of brain metastases compared with other … reached). Patients with brain metastases had an intracranial response … TKD mutations and active brain metastases (cohort 4). The …
New Zongertinib Data from Boehringer Shows Sustained, Clinically Meaningful Results in Advanced NSCLC Patients 29 Apr 2025 21:27 GMT
… in previously treated patients with brain metastases, with 41% achieving response and …
Boehringer’s HER2-mutated lung cancer drug shows sustained benefit for 14 months 29 Apr 2025 13:18 GMT
… previously treated patients who had brain metastases showed that 41% achieved response …
FDA Clears INTRABEAM 700 as Supportive Device for Intraoperative Radiation Therapy 29 Apr 2025 11:11 GMT
… ), phase 2 INTRAMET study of brain metastases (results expected in 2026), phase …
Nano-Encapsulated Taro Lectin Can Cross an in vitro Blood-Brain Barrier, Induce Apoptosis and Autophagy and Inhibit the Migration of Human U-87 MG Glioblastoma Cells 29 Apr 2025 07:40 GMT
… (2b3-101) in patients with brain metastases (BM) from solid tumors or …
Early ctDNA Clearance Is Associated With Response to Daraxonrasib in RAS-Mutant NSCLC 29 Apr 2025 03:38 GMT
… or current smokers, 26% had brain metastases at baseline, and 51% had …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS